The BEACON Act establishes an Inspector General (IG) for the Executive Office of the President (EOP), requiring the President to appoint one within 120 days of the bill's enactment. It grants the President authority to temporarily block the EOP IG from investigating sensitive matters involving confidential sources, intelligence, or undercover operations, but mandates written notification to the IG and congressional committees within 30 days of such a block. The bill also requires the EOP IG to submit semiannual reports to Congress detailing oversight activities, corrective actions, and any restrictions on accessing information, plus annual audits of the EOP IG office itself. Additionally, it mandates two annual evaluations of EOP classification practices to address potential misclassification of sensitive materials.
HR 4482, the Stop NOAA Closures Act, imposes a temporary moratorium on closing, suspending, or limiting access to National Oceanic and Atmospheric Administration (NOAA) facilities, effective until a report is submitted to Congress by January 21, 2029. The bill requires NOAA and the General Services Administration to submit detailed reports to specific congressional committees before any future facility closure, suspension, lease termination, or consolidation - outlining cost-benefit analyses, service impacts, and justification. Exceptions apply only for emergencies posing immediate threats to personnel safety. This bill directly affects NOAA's facility management decisions and mandates congressional oversight for future closures.
The Price Gouging Prevention Act of 2025 makes it unlawful for businesses to sell goods or services at grossly excessive prices during exceptional market shocks like natural disasters, public health emergencies, or other major disruptions. The bill establishes specific thresholds (such as $100 million in annual revenue for small businesses) and requires businesses to demonstrate that price increases were due to uncontrollable costs, rather than exploiting market conditions. It creates a presumption of violation for businesses with "unfair leverage" (defined as having significant market dominance or revenue), and requires companies to disclose pricing strategies in SEC filings during market shocks. The Federal Trade Commission and state attorneys general would enforce the law, with civil penalties up to 5% of a company's revenue. The law includes annual inflation adjustments for certain financial thresholds starting in 2026.
This bill establishes new requirements for food additives to be deemed "generally recognized as safe" (GRAS) under FDA oversight. Manufacturers must now submit detailed safety data - including evidence showing no carcinogenicity, reproductive toxicity, or developmental toxicity - to the FDA for review, replacing the previous reliance on historical use. The FDA must publicly post submissions, allow 60 days for public comment, and issue written determinations within a set timeline. Additionally, the bill mandates the FDA to reassess the safety of at least 10 food substances every three years, prioritizing those under existing petitions or regulations. It directly affects food manufacturers and the FDA, creating a more rigorous, evidence-based process for food additive safety.
This bill requires the Department of Homeland Security (DHS) to keep all personal information from DACA applications confidential. It prohibits sharing this data with U.S. Immigration and Customs Enforcement (ICE), U.S. Customs and Border Protection (CBP), or state/local law enforcement for any purpose other than administering the DACA program. Limited exceptions allow sharing only to prevent fraud, address specific national security threats, or investigate felonies unrelated to immigration status. The law directly protects DACA applicants and recipients by preventing their personal details from being used against them by law enforcement.
This bill creates a public database of residential appraisal data to increase transparency in mortgage lending. It requires major mortgage agencies (Fannie Mae, Freddie Mac, FHA, USDA, VA) to share appraisal data with the Federal Housing Finance Agency, including property details, appraisal methods, and borrower demographics like race and ethnicity. The data will be made publicly available in searchable formats to help identify potential issues in how appraisals are conducted across different communities. It also establishes a process for borrowers to request a review of an appraisal they believe is inaccurate or reflects discrimination.
This bill creates a federal grant program to help schools recruit and retain paraprofessionals - school support staff like teaching assistants - who work directly with students but lack full teaching credentials. It allocates funds to states based on prior Title I education funding, requiring states to prioritize schools serving high numbers of low-income students or designated "high-need" schools. Funds can be used for mentoring programs, professional development, credentialing (like special education or English learner certificates), and wage increases or bonuses for paraprofessionals. The program mandates annual reporting on wage baselines, paraprofessional numbers, and how funds were used to address shortages.
The Price Gouging Prevention Act of 2025 prohibits selling goods or services at grossly excessive prices during exceptional market shocks like natural disasters, energy shortages, or public health emergencies. It creates a presumption of violation when companies with "unfair leverage" (revenue over $1 billion, dominant market position, or other factors) increase prices beyond normal market fluctuations. The law requires public companies to disclose detailed pricing information in SEC filings during these emergencies, including explanations for price increases and how costs affected pricing. The Federal Trade Commission and state attorneys general would enforce the law, with civil penalties up to 5% of a company's revenue for violations. The bill also appropriates $1 billion to fund FTC enforcement efforts.
HR 4516, the Saving Lives and Taxpayer Dollars Act, prohibits the U.S. government or its aid partners from destroying food, medicine, vaccines, or other foreign assistance commodities before they expire, requiring these items to be redirected to intended beneficiaries instead. The bill mandates that agencies like USAID, State, and Agriculture must make every effort to donate or sell expired aid items to those in need before disposal. It also requires annual reports to Congress detailing any expired, spoiled, or destroyed aid items, including reasons for not redirecting them and associated costs. This directly affects U.S. foreign aid agencies and their global partners, ensuring aid reaches people facing hunger, disease, or health crises rather than being wasted.
This bill requires Medicaid programs to cover specific treatments for individuals with breast or cervical cancer. It adds a new provision to Medicaid rules that explicitly includes these patients in mandatory coverage, ensuring states must provide necessary care. The bill also mandates that Medicaid cover breast reconstruction surgery following a medically necessary mastectomy. These changes directly affect Medicaid beneficiaries diagnosed with breast or cervical cancer who need these specific treatments. The policy update removes gaps in existing coverage for these critical cancer care services.
HR 4545, the Medicare Breast Reconstruction Access and Information Act, requires healthcare providers to inform Medicare patients about coverage for breast reconstruction surgery before performing a mastectomy. The bill amends the Social Security Act to mandate that suppliers providing a mastectomy must explain that reconstruction is covered under Medicare's national coverage determination 140.2 and document this discussion in the patient's medical record. This applies specifically to Medicare beneficiaries undergoing medically necessary mastectomies. The law ensures patients receive clear information about existing coverage options prior to surgery, without changing Medicare's benefit structure.
This bill prohibits federal and state governments from restricting access to FDA-approved medicines. It guarantees individuals the right to obtain these medicines without coercion and allows healthcare providers (like doctors and pharmacists) to prescribe or refer for them. The law blocks governments from implementing rules that single out or hinder the sale, provision, or use of FDA-approved drugs, such as bans on specific medicines or barriers to patient access. It does not affect the FDA's drug approval process or existing health insurance coverage requirements.
